Skip to main content
Alexander Black, MD, Oncology, Valencia, CA, Henry Mayo Newhall Hospital

AlexanderCBlackMD

Oncology Valencia, CA

Hematologic Oncology

Clinical Professor of Medicine, UCLA

Dr. Black is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Black's full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1989
  • Columbia-Presbyterian Medical Center, Columbia University
    Columbia-Presbyterian Medical Center, Columbia University1983 - 1987
  • Columbia-Presbyterian Medical Center, Columbia University
    Columbia-Presbyterian Medical Center, Columbia University1983 - 1987
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1984 - 1986
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1983
  • Harvard University
    Harvard UniversityBA, Biochemistry, 1976 - 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Valencia site principal investigator (PI) for the Southwest Oncology Group (SWOG) UCLA School of Medicine, 2012
  • Associate Director Santa Clarita and Pasadena UCLA Cancer Centers, 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • A clinical, hematological and immunological analysis of 21 HTLV II-infected intravenous drug users.  
    Rosenblatt JD, Plaeger-Marshall S, Giorgi JV, Chen ISY, Chin E, Wang HJ, Canavaggio M, Swanson P, Black AC, Lee H, Blood 76: 409-417
  • Different cis acting regions of the HTLV II 5’ LTR are involved in regulation of gene expression by Rex.  
    Black AC, Chen ISY, Arrigo SJ, Ruland CT, Chin E, Allogimento T, Rosenblatt JD, Virology 181:433-444
  • HTLV II Rex protein binds specifically to RNA sequences of the HTLV LTR but poorly to the HIV I RRE.  
    Yip MT, Dynan WS, Green PL, Black AC, Arrigo SJ, Torbati A, Heaphy S, Ruland C, Rosenblatt JD, Chen ISY, J Virol 65: 2261-2272
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Constitutive expression of HTLV I Tax in Jurkat T cells induces overlapping but distinct changes in cellular gene expression as compared with HTLV I transformed cells.
    Black AC, Chun S, Luo J, Emmanouilides C, ASH annual meeting
  • HTLV I transformed cells are resistant to Gamma-radiation induced apoptosis despite high levels of Wild type p53.
    Black AC, Luo J, Tabibzadeh S, Emmanouilides C, ASH annual meeting
  • Prevention of experimental acute GVHD with galectin-1 and effects on immunologic reconstitution.
    Emmanouilides C, Hoffman D, Baum LG, Dao P, Sphaner A, Firouzalteh P, Luo J, Territo M, Baldwin G, Black AC, ASH annual meeting
  • Join now to see all

Press Mentions

  • At 38, Brian Coyne Wasn’t Expecting the Results He Received from His First Colonoscopy
    At 38, Brian Coyne Wasn’t Expecting the Results He Received from His First ColonoscopyMarch 3rd, 2023

Hospital Affiliations